Pancytopenia Related to Azathioprine — An Enzyme Deficiency Caused by a Common Genetic Polymorphism: A Review

Odlind B Hartvig P Lindstrom B Lonnerholm G Tufveson G Grefberg N . Serum azathioprine and 6-mercaptopurine levels and immunosuppressive activity after azathioprine in uraemic patients. Int J Immuno-pharmacol 1986;8:1–11.

Ding TL Gambertoglio JG Amend WJC Birnbaum J Benet LZ . Azathioprine bioavailability and pharmacokinetics in kidney transplant patients. Clin Pharmacol Ther 1980;27:250.

Weinshilboum RM Sladek SL . Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980;32:651–62.

Grant DM Tang BK Campbell ME Kalow W . Effect of allopurinol on caffeine disposition in man. Br J Clin Pharmacol 1986;21:454–8.

Guerciolini R Szumlanski C Weinshilboum RM . Human liver xanthine oxidase: Nature and extent of individual variation. Clin Pharmacol Ther 1991;50:663–72.

Sauer BH Hantke U Wilmanns W . Azathioprine lympho-toxicity. Potentially lethal damage by its imidazole derivatives. Arzneim-Forsch/Drug Res 1988;38:820–4.

Maddocks JL Lennard L Amess J Amos R Thomas Meyrick R . Azathioprine and severe bone marrow depression. Lancet 1986;i:156.

Lennard L Van Loon JA Weinshilboum RM . Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 1989;46:149–54.

Lennard L Van Loon JA Lilleyman JS Weinshilboum RM . Thiopurine pharmacogenetics in leukaemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther 1987;41:18–25.

Lennard L Lilleyman JS Van Loon J Weinshilboum RM . Childhood acute lymphoblastic leukaemia: Genetic variation in response to 6-mercaptopurine. Lancet 1990;336:225–9.

Szumlanski CL Scott MC Weinshilboum RM . Thiopurine methyltransferase pharmacogenetics: Human liver enzyme activity. Clin Pharmacol Ther 1988;43:134.

Lennard L . Assay of 6-thionosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells. J Chromatog 1987;423:169–78.

Weinshilboum RM Raymond FA Pazimino PA . Human erythrocyte thiopurine methyl transferase: Radiochemical microassay and biochemical properties. Clin Chim Acta 1978;85:323–33.

Witte AS Cornblath DR Schatz NJ Lisak RP . Monitoring azathioprine therapy in myasthenia gravis. Neurology 1986;36:1533–4.

Lennard L Murphy MF Maddocks JL . Severe megaloblastic anaemia associated with abnormal azathioprine metabolism. Br J Clin Pharmacol 1984;17:171–2.

Jeurissen MEC Boerbooms AMTh Van De Putte LBA . Pancytopenia related to azathioprine in rheumatoid arthritis. Ann Rheum Dis 1988;47:503–5.

Kolle G . Knochenmarksschadigung bei immunsuppressiver therapie der juvenilen rheumatoiden arthritis und des Still-syndromes mit azathioprin. Dtsch Med Wochenschr 1969;94:2268–73.

Lorenzen I Brun C Videbaek A . Treatment of immunological diseases with cytostatics. Acta Med Scand 1969;185:501–6.

Ginzler E Sharon E Diamond H Kaplan D . Long-term maintenance therapy with azathioprine in systemic lupus erythematosus. Arthritis Rheum 1975;18:27–34.

Singleton JW Law DH Kelley ML Mekhjian HS Sturdevant RAL . National cooperative Crohn's disease study: Adverse reactions to study drugs. Gastroenterology 1979;77:870–82.

Pollak R Nishikawa RA Mozes MF Jonasson O . Azathioprine-induced leucopenia: Clinical significance in renal transplantation. J Surg Res 1980;29:258–64.

Present DH Korelitz BI Wisch N Glass JL Sachar DB Pasternack BS . Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980;302:981–7.

Mertens HG Hertel G Reuther P Ricker K . Effect of immunosuppressive drugs (Azathioprine). Ann NY Acad Sci 1981;377:691–9.

Haas J Patzold U . Ueber die Blutbildveraenderungen bei langfristiger Behandlung der Multipen Sklerose und Myasthenie mit azathioprin. Nervenarzt 1982;53:105–9.

Kissel JT Levy RJ Mendell JR Griggs RC . Azathioprine toxicity in neuromuscular disease. Neurology 1986;36:35–9.

Kvien TK Hoyeraal HM Sandstad B . Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: A single centre double blind comparative study. J Rheumatol 1986;13:118–23.

Hohlfeld R Michels M Heininger K Besinger U Toyka KV . Azathioprine toxicity during long-term immunosuppression of generalised myasthenia gravis. Neurology 1988;38:258–61.

Denman EJ Denman AM Greenwood BM Gall D Heath RB . Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis 1970;29:220–31.

O'Donoghue DP Dawson AM Powell-Tuck J Brown RL Lennard-Jones JE . Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978;ii:955–7.

Bacon BR Treuhaft WH Goodman AM . Azathioprine-induced pancytopenia. Occurrence in two patients with connective-tissue diseases. Arch Intern Med 1981;141:223–6.

Goadsby PJ Day RO Kwan YL Miners J Birkett DJ . 6-mercaptopurine-related leucopenia and in vivo xanthine oxidase activity. Lancet 1986;ii:869–70.

Verhelst JA Van Den Enden E Mathys R . Rapidly evolving azathioprine induced pancytopenia. J Rheumatol 1987;14:862.

Nossent JC Swaak AJG . Pancytopenia in systemic lupus erythematosus related to azathioprine. J Intern Med 1990;227:69–72.

Whisnant JK Pelkey R . Rheumatoid arthritis: Treatment with azathioprine (IMURAN(R)). Clinical side-effects and laboratory abnormalities. Ann Rheum Dis 1982;41(Suppl):44–66.

Lawson DH Lovatt GE Gurton CS Hennings RC . Adverse effects of azathioprine. Adv Drug React Ac Pois Rev 1984;3:161–71.

Decker JL Steinberg AD . Immunoregulatory drugs. In: McCarthy DJ , ed. Arthritis and allied conditions. Philadelphia: Lee & Febiger, 1985;529–30.

Lennard L Harrington CI Wood M Maddocks JL . Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgaris. Br J Clin Pharmacol 1987;23:229–33.

APBI. Association of the British Pharmaceutical Industry Data Sheet Compendium. Datapharm Publications Ltd., 1990–1991:307–8, 317–18.